HEARTBEAM INC (BEAT)
US42238H1086 - Common Stock
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
HeartBeam Reports Third Quarter 2024 Results
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, has appointed a new chief artificial intelligence (“AI”) scientist: Lance Myers, PhD. According to the announcement, Myers is the former head of data science at Verily, formerly Google Life Sciences. A renowned industry leader and […]
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has named a seasoned medtech leader as its new chief financial officer. According to the announcement, Timothy Cruickshank has accepted the role of chief financial officer, effective immediately; he succeeds Richard Brounstein, who announced his retirement. Cruickshank has […]
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is reporting on financial and operations results for its second quarter 2024, the period that ended June 30, 2024. Highlights of the report include steady progress made toward key clinical and regulatory milestones on its HeartBeam AIMIGo(TM) System, […]
BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024
BEAT stock results show that HeartBeam missed analyst estimates for earnings per share the second quarter of 2024.
BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips HeartBeam (NASDAQ:BEAT) just reported results for the second quarter of 2024.He...
HeartBeam Reports Second Quarter 2024 Results
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
HeartBeam Added to Russell Microcap® Index
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024
BEAT stock results show that HeartBeam missed analyst estimates for earnings per share the first quarter of 2024.
BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips HeartBeam (NASDAQ:BEAT) just reported results for the first quarter of 2024.Hea...
HeartBeam Reports First Quarter 2024 Results
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023
BEAT stock results show that HeartBeam met analyst estimates for earnings per share the fourth quarter of 2023.
BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips HeartBeam (NASDAQ:BEAT) just reported results for the fourth quarter of 2023.He...
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
